Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shoulder InnovationsFRA:VB3 -0.59%12 Days Sales Outstanding is 56.80 as of Jun. 2026, which is 0% above its 10-year median of 56.64. GuruFocus rates FRA:VB3 with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 809 Medical Devices & Instruments companies, Shoulder Innovations ranks better than 66.25% on this metric.
The historical rank and industry rank for Shoulder Innovations's Days Sales Outstanding or its related term are showing as below:
FRA:VB3'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.64 Med: 56.64 Max: 88.87
Current: 53.06
During the past 3 years, Shoulder Innovations's highest Days Sales Outstanding was 88.87. The lowest was 51.64. And the median was 56.64.
FRA:VB3's Days Sales Outstanding is ranked better than 66.25% of 809
companies
in the Medical Devices & Instruments industry
Industry Median: 64.94
vs FRA:VB3: 53.06
Shoulder Innovations's Days Sales Outstanding
declined
from Jun. 2025 (57.61) to Jun. 2026 (56.80).
Shoulder Innovations (FRA:VB3) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Shoulder Innovations Days Sales Outstanding Related Terms
Shoulder Innovations Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Shoulder Innovations's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VB3 vs MASS, PACB, SGHT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Shoulder Innovations's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shoulder Innovations Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shoulder Innovations's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Shoulder Innovations's Days Sales Outstanding falls into.
Shoulder Innovations Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shoulder Innovations (FRA:VB3) has a Days Sales Outstanding of 56.80 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Shoulder Innovations and its competitors. This is near median its historical median of 56.64. Over the past decade, Shoulder Innovations' Days Sales Outstanding has ranged from 51.64 to 88.87. According to the industry distribution chart, Shoulder Innovations ranks #273 out of 809 companies in the Medical Devices & Instruments industry, placing it in the top 33.7%.
Is Shoulder Innovations' Days Sales Outstanding too high?
Shoulder Innovations' current Days Sales Outstanding of 56.80 is near median its 10-year median of 56.64. Over the past 10 years, this metric has ranged from a low of 51.64 to a high of 88.87. The Medical Devices & Instruments industry median Days Sales Outstanding is 64.94. Shoulder Innovations' value of 56.80 is 12.5% below this industry median. Based on the distribution chart, Shoulder Innovations ranks #273 out of 809 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shoulder Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' Days Sales Outstanding compare to MASS and PACB?
According to the Medical Devices & Instruments industry distribution chart, Shoulder Innovations ranks #273 out of 809 companies for Days Sales Outstanding. This puts Shoulder Innovations in the upper half of its industry. The industry median Days Sales Outstanding is 64.94. Shoulder Innovations' value of 56.80 is 12.5% below this benchmark. Historically, Shoulder Innovations' own Days Sales Outstanding has ranged from 51.64 to 88.87 over the past decade. While the company's 10-year median is 56.64 vs. the industry median of 64.94, Shoulder Innovations has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 64.94, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shoulder Innovations's current Days Sales Outstanding of 56.80 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Shoulder Innovations and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 64.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shoulder Innovations's current Days Sales Outstanding is 56.80, which is near median its own 10-year median of 56.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (FRA:VB3) has a current Days Sales Outstanding of 56.80. The current Days Sales Outstanding is 56.80, which is near median its 10-year median of 56.64 and 12.5% below the Medical Devices & Instruments industry median of 64.94. Shoulder Innovations' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Shoulder Innovations (FRA:VB3), the current Days Sales Outstanding is 56.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
12GF Score
Get the complete analysis for FRA:VB3
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VB3 has been successfully added to your 
